These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 2435411)
1. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. I. Dose-response study on enzyme content and secretion, cholecystokinin release and pancreatic fine structure. Rausch U; Adler G; Weidenbach H; Weidenbach F; Rudolff D; Koop I; Kern HF Cell Tissue Res; 1987 Jan; 247(1):187-93. PubMed ID: 2435411 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. III. Changes in DNA synthesis and mitotic activity. Elsässer HP; Puplat D; Adler G; Kern HF Cell Tissue Res; 1990 Oct; 262(1):143-8. PubMed ID: 2257606 [TBL] [Abstract][Full Text] [Related]
3. Effect of atropine on feedback regulation of pancreatic secretion in rats. Weidenbach H; Printz H; Göke B; Koop I; Schafmayer A; Adler G Res Exp Med (Berl); 1989; 189(3):221-8. PubMed ID: 2473503 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. II. Regulation of total protein and individual enzyme biosynthesis. Rausch U; Weidenbach H; Adler G; Kern HF Cell Tissue Res; 1987 Jul; 249(1):63-7. PubMed ID: 2441868 [TBL] [Abstract][Full Text] [Related]
5. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate). Göke B; Printz H; Koop I; Rausch U; Richter G; Arnold R; Adler G Pancreas; 1986; 1(6):509-15. PubMed ID: 3562444 [TBL] [Abstract][Full Text] [Related]
6. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats. Miyasaka K; Nakamura R; Kitani K J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate). Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267 [TBL] [Abstract][Full Text] [Related]
8. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats. Göke B; Fenchel K; Knobloch S; Arnold R; Adler G Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Niederau C; Liddle RA; Williams JA; Grendell JH Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964 [TBL] [Abstract][Full Text] [Related]
10. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion. Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W Digestion; 1984; 30(3):171-8. PubMed ID: 6209186 [TBL] [Abstract][Full Text] [Related]
11. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas. Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314 [TBL] [Abstract][Full Text] [Related]
12. Adaptation of the human pancreas to inhibition of luminal proteolytic activity. Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044 [TBL] [Abstract][Full Text] [Related]
13. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat. Varga G; Kisfalvi K; D'Amato M; Scarpignato C J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804 [TBL] [Abstract][Full Text] [Related]
14. Role of intraduodenal proteases in plasma cholecystokinin and pancreaticobiliary responses to protein and amino acids. Thimister PW; Hopman WP; Sloots CE; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB Gastroenterology; 1996 Feb; 110(2):567-75. PubMed ID: 8566605 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion. Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of single and repeated administrations of a protease inhibitor (Camostate) on pancreatic secretion in man. Adler G; Müllenhoff A; Bozkurt T; Göke B; Koop I; Arnold R Scand J Gastroenterol; 1988 Mar; 23(2):158-62. PubMed ID: 3363288 [TBL] [Abstract][Full Text] [Related]
17. Secretory responses of hypertrophied rat pancreas induced by repeated oral administrations of a synthetic protease inhibitor. Yonezawa H Jpn J Physiol; 1983; 33(2):183-95. PubMed ID: 6876500 [TBL] [Abstract][Full Text] [Related]
18. General and selective inhibition of pancreatic enzyme discharge using a proteinase inhibitor (FOY-305). Adler G; Rausch U; Weidenbach F; Arnold R; Kern HF Klin Wochenschr; 1984 May; 62(9):406-11. PubMed ID: 6202931 [TBL] [Abstract][Full Text] [Related]
19. Okadaic acid disrupts Golgi structure and impairs enzyme synthesis and secretion in the rat pancreas. Waschulewski IH; Kruse ML; Agricola B; Kern HF; Schmidt WE Am J Physiol; 1996 Jun; 270(6 Pt 1):G939-47. PubMed ID: 8764200 [TBL] [Abstract][Full Text] [Related]
20. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas. Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]